Park Ha Biological Sets 1-for-8 Reverse Split Effective August 6 to Regain Nasdaq Compliance

summarizeSummary

Park Ha Biological Technology will execute a 1-for-8 reverse stock split on August 6, 2026, reducing outstanding shares to approximately 2.3 million in a bid to maintain Nasdaq listing compliance.

check_boxKey Events · Corporate Governance and Compliance · BYAH

• 1-for-8 Reverse Split Effective August 6

  The reverse stock split will consolidate every 8 existing shares into 1, reducing outstanding shares from 18,764,216 to approximately 2,345,527. Trading on a split-adjusted basis begins August 6, 2026.

• Nasdaq Compliance Bid

  The reverse split is designed to raise the stock price above Nasdaq's $1.00 minimum bid requirement. The company previously relied on home-country exemptions to bypass governance standards, signaling ongoing listing pressure.

• Post-Split Capital Structure

  Authorized shares remain at 37.5 billion (30B Class A, 7.5B Class B) with par value adjusted to $0.008. The massive authorized share count leaves room for extreme future dilution.

• Recent Distress Context

  The reverse split follows a $1.8 million private placement at $0.18 per share (a 47% discount to the current price) and a $918K net loss with cash collapsing to critical levels.

auto_awesomeAnalysis · BYAH · Industrial Applications And Services

Park Ha Biological Technology is implementing a 1-for-8 reverse stock split on August 6, 2026, following shareholder approval on July 13. The split reduces outstanding shares from 18.8 million to about 2.3 million, aiming to lift the stock price above Nasdaq's minimum bid requirement. This comes after the company relied on home-country exemptions to bypass Nasdaq governance rules and raised $1.8 million in a deeply discounted private placement. The reverse split is a critical step to avoid delisting, but it does not address the underlying financial distress—the company reported a $918K loss and collapsing cash reserves in its latest filing.